Nausea and vomiting risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
==Risk factors== | ==Risk factors== | ||
*Risk factors for [[nausea]] and [[vomiting]] vary with underlying cause. | |||
*Well established [[risk factors]] for [[postoperative]] nausea and vomiting include: <ref name="pmid16717343">{{cite journal |vauthors=Gan TJ |title=Risk factors for postoperative nausea and vomiting |journal=Anesth Analg |volume=102 |issue=6 |pages=1884–98 |date=June 2006 |pmid=16717343 |doi=10.1213/01.ANE.0000219597.16143.4D |url=}}</ref> | |||
** female gender post [[puberty]] | |||
** nonsmoking status | |||
** history of postoperative nausea and vomiting | |||
** history of [[motion sickness]] | |||
** childhood after [[infancy]] and younger adulthood | |||
** increasing duration of surgery | |||
** use of volatile [[anesthetics]], [[nitrous oxide]], large-dose [[neostigmine]], or [[intraoperative]] or [[postoperative]] [[opioids]] | |||
* Possible risk factors for postoperative nausea and vomiting include: <ref name="pmid16717343">{{cite journal |vauthors=Gan TJ |title=Risk factors for postoperative nausea and vomiting |journal=Anesth Analg |volume=102 |issue=6 |pages=1884–98 |date=June 2006 |pmid=16717343 |doi=10.1213/01.ANE.0000219597.16143.4D |url=}}</ref> | |||
** history of [[migraine]] | |||
** history of postoperative nausea and vomiting or [[motion sickness]] in a child's parent or sibling | |||
** intense preoperative [[anxiety]] | |||
** certain ethnicities or surgery types | |||
** decreased [[perioperative]] fluids | |||
** [[crystalloid]] versus [[colloid]] administration | |||
** increasing duration of [[anesthesia]] | |||
** general versus regional [[anesthesia]] or [[sedation]] | |||
** balanced versus total IV anesthesia | |||
** use of longer-acting versus shorter-acting [[opioids]] | |||
* Risk factors for nausea and vomiting in [[pregnancy]] include: <ref name="pmid16879499">{{cite journal |vauthors=Louik C, Hernandez-Diaz S, Werler MM, Mitchell AA |title=Nausea and vomiting in pregnancy: maternal characteristics and risk factors |journal=Paediatr Perinat Epidemiol |volume=20 |issue=4 |pages=270–8 |date=July 2006 |pmid=16879499 |doi=10.1111/j.1365-3016.2006.00723.x |url=}}</ref> | |||
** increased number of prior [[miscarriage]]s | |||
** increased [[gravidity]] | |||
** risk decreased with increasing age | |||
** [[twin]] births | |||
** Increased risk of nausea and vomiting after [[first trimester]] is seen in women who are less well educated, have lower incomes, and more likely in black women. | |||
*Risk factors for [[chemotherapy]] induced nausea and vomiting: <ref name="pmid23480814">{{cite journal |vauthors=Sekine I, Segawa Y, Kubota K, Saeki T |title=Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis |journal=Cancer Sci |volume=104 |issue=6 |pages=711–7 |date=June 2013 |pmid=23480814 |pmc=7657206 |doi=10.1111/cas.12146 |url=}}</ref> <ref name="HeskethAapro2009">{{cite journal|last1=Hesketh|first1=Paul J.|last2=Aapro|first2=Matti|last3=Street|first3=James C.|last4=Carides|first4=Alexandra D.|title=Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy|journal=Supportive Care in Cancer|volume=18|issue=9|year=2009|pages=1171–1177|issn=0941-4355|doi=10.1007/s00520-009-0737-9}}</ref> | |||
** age less than 50 years | |||
** female gender | |||
** history of [[nausea]] and [[vomiting]] or [[motion sickness]] | |||
** type of [[antineoplastic]] agent and how it is used | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 02:30, 21 January 2021
|
Nausea and vomiting Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nausea and vomiting risk factors On the Web |
|
American Roentgen Ray Society Images of Nausea and vomiting risk factors |
|
Risk calculators and risk factors for Nausea and vomiting risk factors |
Overview
Risk factors
- Well established risk factors for postoperative nausea and vomiting include: [1]
- female gender post puberty
- nonsmoking status
- history of postoperative nausea and vomiting
- history of motion sickness
- childhood after infancy and younger adulthood
- increasing duration of surgery
- use of volatile anesthetics, nitrous oxide, large-dose neostigmine, or intraoperative or postoperative opioids
- Possible risk factors for postoperative nausea and vomiting include: [1]
- history of migraine
- history of postoperative nausea and vomiting or motion sickness in a child's parent or sibling
- intense preoperative anxiety
- certain ethnicities or surgery types
- decreased perioperative fluids
- crystalloid versus colloid administration
- increasing duration of anesthesia
- general versus regional anesthesia or sedation
- balanced versus total IV anesthesia
- use of longer-acting versus shorter-acting opioids
- Risk factors for nausea and vomiting in pregnancy include: [2]
- increased number of prior miscarriages
- increased gravidity
- risk decreased with increasing age
- twin births
- Increased risk of nausea and vomiting after first trimester is seen in women who are less well educated, have lower incomes, and more likely in black women.
- Risk factors for chemotherapy induced nausea and vomiting: [3] [4]
- age less than 50 years
- female gender
- history of nausea and vomiting or motion sickness
- type of antineoplastic agent and how it is used
References
- ↑ 1.0 1.1 Gan TJ (June 2006). "Risk factors for postoperative nausea and vomiting". Anesth Analg. 102 (6): 1884–98. doi:10.1213/01.ANE.0000219597.16143.4D. PMID 16717343.
- ↑ Louik C, Hernandez-Diaz S, Werler MM, Mitchell AA (July 2006). "Nausea and vomiting in pregnancy: maternal characteristics and risk factors". Paediatr Perinat Epidemiol. 20 (4): 270–8. doi:10.1111/j.1365-3016.2006.00723.x. PMID 16879499.
- ↑ Sekine I, Segawa Y, Kubota K, Saeki T (June 2013). "Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis". Cancer Sci. 104 (6): 711–7. doi:10.1111/cas.12146. PMC 7657206 Check
|pmc=value (help). PMID 23480814. - ↑ Hesketh, Paul J.; Aapro, Matti; Street, James C.; Carides, Alexandra D. (2009). "Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy". Supportive Care in Cancer. 18 (9): 1171–1177. doi:10.1007/s00520-009-0737-9. ISSN 0941-4355.